UPDATE: Sheller, P.C. has now been the law firm of record coordinating with the U.S. Department of Justice in reaching more than $6.4 billion in whistleblower settlements in the last seven years.
For this video: 2009 has seen two historic pharmaceutical settlements: a $1.4 billion settlement involving Eli Lilly's Zyprexa in January and Pfizer's $2.3 billion settlement earlier this month.
Both times, the Philadelphia-based Sheller, P.C. law firm's unique makeup has been central in aiding the U.S. government recoup record numbers of dollars for federal and state governments, taxpayers and whistleblowers.
In the Pfizer matter, lawyer Stephen Sheller represented Ronald Rainero, a Pfizer employee-turned-whistleblower who experienced first-hand the pressure to promote Zyvox, a powerful antibiotic, off-label.
The company promoted Zyvox as superior to similar drugs, even though the FDA sent a warning letter to Pfizer in 2005 about these very claims. Off-label promotion helped push Zyvox sales to more than $1 billion – all the while bilking the government and putting the public's health at risk. Rainero blew the whistle, working in concert with the U.S. Attorney's office in Boston and Sheller lawyers.
"Our firm is uniquely qualified to handle these qui tam cases," states Sheller who himself brings four decades of civil litigation experience successfully battling automotive, tobacco, pharmaceutical and other corporate giants.
"Whistleblowers know that they can trust us," says Sheller. "That's one reason we have helped recoup $3.7 Billion for the government in just nine months. From our standpoint this is the work firms should be doing. And," he added "we're not finished yet."
For more information, visit www.Sheller.com.